Position in NVS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$227,139
-$39,639 QoQ
Shares Held
1,487
-23.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CAUSEWAY CAPITAL MANAGEMENT LLC holds $1,766,978,720 across 8 Drug Manufacturers - General names. NVS ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
7,421,749 | $1,463,717,337 | |
| 2 | MRK |
Merck & Co., Inc.
|
854,212 | $102,753,161 | |
| 3 | PFE |
Pfizer Inc
|
1,914,219 | $53,751,269 | |
| 4 | BIIB |
Biogen Inc.
|
280,783 | $51,475,947 | |
| 5 | SNY |
Sanofi
|
1,064,516 | $51,288,380 | |
| 6 | NVO |
Novo Nordisk A S
|
1,174,213 | $43,152,327 | |
| 7 | GSK |
GSK plc
|
11,110 | $613,160 | |
| 8 | NVS |
Novartis AG
This page
|
1,487 | $227,139 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $227,139 | 1,487 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $266,778 | 1,935 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $263,404 | 2,054 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $252,184 | 2,084 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $472,229 | 4,236 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $570,820 | 5,866 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $849,077 | 7,382 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $21,540,584 | 202,335 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $23,163,739 | 239,468 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $21,111,716 | 209,089 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,049,755 | 187,019 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $22,760,048 | 225,548 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $22,605,044 | 245,707 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $20,215,319 | 222,832 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $20,585,788 | 270,830 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $26,402,184 | 312,341 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $34,377,115 | 391,762 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $33,410,653 | 381,967 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $32,803,266 | 401,116 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $38,957,837 | 426,982 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $33,966,161 | 397,358 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $28,855,730 | 305,578 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $27,393,965 | 315,018 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $28,489,085 | 326,186 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $26,939,218 | 326,734 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||